Table 2.
An overview of the biomarker potential of lncRNAs for hepatocellular and pancreatic cancer.
| lncRNA | Cancer type | Sample | Expression | Clinical application | Reference |
|---|---|---|---|---|---|
| HULC | HCC | Tissue/plasma | Up | Diagnosis/unfavorable prognosis | [123] |
|
| |||||
| uc003wbd | HCC | Serum | Up | Diagnosis | [124] |
|
| |||||
| AF085935 | HCC | Serum | Up | Diagnosis | [124] |
|
| |||||
| HEIE | HCC | Tissue | Up | Unfavorable prognosis | [51] |
|
| |||||
| MVIH | HCC | Tissue | Up | Unfavorable prognosis | [128] |
|
| |||||
| URCH | HCC | Tissue | Up | Unfavorable prognosis | [129] |
|
| |||||
| lncRNA-ATB | HCC | Tissue | Up | Unfavorable prognosis | [130] |
|
| |||||
| HOTTIP | HCC | Tissue | Up | Unfavorable prognosis | [131] |
|
| |||||
| hDREH | HCC | Tissue | Down | Favorable prognosis | [76] |
|
| |||||
| LET | HCC | Tissue | Down | Favorable prognosis | [125] |
|
| |||||
| GAS5 | HCC | Tissue | Down | Favorable prognosis | [133] |
|
| |||||
| MALAT1 | PDAC | FFPE tissues | Up | Unfavorable prognosis | [134, 135] |
|
| |||||
| ENST00000480739 | PDAC | Tissue | Down | Favorable prognosis | [3] |
|
| |||||
| BC008363 | PDAC | Tissue | Down | Favorable prognosis | [138] |
|
| |||||
| HOTAIR | HCC | Tissue | Up | Unfavorable prognosis | [127] |
| Pancreatic cancer | Tissue | Up | Unfavorable prognosis | [136] | |
|
| |||||
| PVT1 | HCC | Tissue | Up | Unfavorable prognosis | [132] |
| PDAC | Tissue | Up | Unfavorable prognosis | [137] | |